Kirko Kirkov insider trades
Open-market stock purchases and sales by Kirko Kirkov, Chief Commercial Officer at Elite Pharmaceuticals Inc /nv/, from SEC Form 4 filings since Sep 6, 2022.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -34%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- ELTP Elite Pharmaceuticals Inc /nv/: 1 buy, last Jul 10, 2025